clinical trials glp 1 Timeline of GLP-1 discovery and development. (a) Key events in clinical trial glp 1 Another

doi: 10.1038/nm0595-417 22 SchankMZhaoJMoormanJPYaoZQ

Peptide Name: BPC-157 (Body Protection Compound-157) Alias: Wolverine peptide Molecular Formula: CHNO Molecular Weight: ~1419.5 g/mol Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Purity: 99% (HPLC verified) Appearance: White to off-white lyophilized powder Form: Sterile freeze-dried vial Storage: -20C recommended for long-term stability Solubility: Water-soluble in laboratory buffer solutions These specifications make high purity BPC-157 suitable for controlled experimental environments requiring consistency and analytical reliability

Mechanistically, GLP-1R activation raises cAMP levels and triggers the PKA/CREB (cAMP-response element-binding protein) signal transduction pathway, which regulates various cellular processes [111]

We use the generic name, since the brand name may differ in different parts of the world